diafyt Medtech
Fun despite diabetes .. we help people with diabetes who have difficulties finding the correct insulin doses.
Fun despite diabetes .. we help people with diabetes who have difficulties finding the correct insulin doses.
diafyt Medtech is a German startup founded in 2016, focusing on AI, healthcare, medical devices, mobile, and machine learning. The company's slogan, "Fun despite diabetes," encapsulates their mission to assist individuals with diabetes in determining the correct insulin doses, addressing the challenge of maintaining physical fitness and a healthy diet.
diafyt's software for automated diabetes therapy aims to predict the precise insulin dosage to control blood sugar levels, ultimately improving the lives of those with diabetes. The technology's innovative algorithm offers a more stable and effective solution, reducing the risk of taking incorrect insulin doses and their serious consequences.
The company recently secured a €15.00K Seed Round investment on 15 February 2021, reflecting investor confidence in their breakthrough approach. For more information, visit diafyt's LinkedIn page (https://www.linkedin.com/pulse/spaß-trotz-diabetes-german-startup-shape-future-wuttke-privat) and Crunchbase profile (https://www.crunchbase.com/organization/diafyt). Overall, diafyt Medtech's innovative software and recent investment position them as a promising player in the medtech industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | €15.00K | - | 15 Feb 2021 | |
| Seed Round | Unknown | - | 10 May 2018 | |
| Seed Round | €300.00K | 1 |
|
02 Mar 2018 |
| Grant | €250.00K | 1 |
|
01 Aug 2017 |
No recent news or press coverage available for diafyt Medtech.
We care about your data, and we'd love to use cookies make your experience better.
